{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:52:04Z","timestamp":1682488324923},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T00:00:00Z","timestamp":1360281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00108-012-3196-1","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T15:49:42Z","timestamp":1360165782000},"page":"315-327","source":"Crossref","is-referenced-by-count":6,"title":["Hyperthyreose"],"prefix":"10.1007","volume":"54","author":[{"given":"M.","family":"Schott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,8]]},"reference":[{"key":"3196_CR1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.autrev.2010.05.021","volume":"9","author":"Zophel","year":"2010","unstructured":"Zophel K, Roggenbuck D, Schott M (2010) Clinical review about TRAb assay\u2019s history. Autoimmun Rev 9:695\u2013700","journal-title":"Autoimmun Rev"},{"key":"3196_CR2","first-page":"566","volume":"Endocrinol","author":"Schott","year":"2009","unstructured":"Schott M, Hermsen D, Broecker-Preuss M et\u00a0al (2009) Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves\u2018 disease (GD): an international multicentre trial. Clin Endocrinol (Oxf) 71:566\u2013573","journal-title":"Clin"},{"key":"3196_CR3","doi-asserted-by":"crossref","unstructured":"Lytton SD, Ponto KA, Kanitz M et\u00a0al (2010) A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2018 orbitopathy. J\u00a0Clin Endocrinol Metab 95:2123\u20132131","DOI":"10.1210\/jc.2009-2470"},{"key":"3196_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-2004-814217","volume":"36","author":"Schott","year":"2004","unstructured":"Schott M, Morgenthaler NG, Fritzen R et\u00a0al (2004) Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves\u2018 disease. Horm Metab Res 36:92\u201396","journal-title":"Horm Metab Res"},{"key":"3196_CR5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1089\/thy.2005.15.1047","volume":"15","author":"Quadbeck","year":"2005","unstructured":"Quadbeck B, Hoermann R, Roggenbuck U et\u00a0al (2005) Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves\u2018 disease. Thyroid 15:1047\u20131054","journal-title":"Thyroid"},{"key":"3196_CR6","first-page":"343","volume":"Klin","author":"Eckstein","year":"2009","unstructured":"Eckstein A, Mann K, Kahaly GJ et\u00a0al (2009) Role of TSH receptor autoantibodies for the diagnosis of Graves\u2018 disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology. Med Klin (Munich) 104:343\u2013348","journal-title":"Med"},{"key":"3196_CR7","doi-asserted-by":"crossref","unstructured":"Giuliani C, Cerrone D, Harii N et\u00a0al (2012) A TSHR-LH\/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in graves\u2018 patients undergoing antithyroid drug (ATD) treatment. J\u00a0Clin Endocrinol Metab 97:E1080\u20131087","DOI":"10.1210\/jc.2011-2897"},{"key":"3196_CR8","doi-asserted-by":"crossref","unstructured":"Eckstein AK, Plicht M, Lax H et\u00a0al (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2018 ophthalmopathy and help to predict severity and outcome of the disease. J\u00a0Clin Endocrinol Metab 91:3464\u20133470","DOI":"10.1210\/jc.2005-2813"},{"key":"3196_CR9","doi-asserted-by":"crossref","unstructured":"Ehlers M, Thiel A, Bernecker C et\u00a0al (2012) Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto\u2019s thyroiditis. J\u00a0Clin Endocrinol Metab 97:1347\u20131354","DOI":"10.1210\/jc.2011-2178"},{"key":"3196_CR10","doi-asserted-by":"crossref","unstructured":"Hollowell JG, Staehling NW, Flanders WD et\u00a0al (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988\u20131994): National Health and Nutrition Examination Survey (NHANES\u00a0III). J\u00a0Clin Endocrinol Metab 87:489\u2013499","DOI":"10.1210\/jc.87.2.489"},{"key":"3196_CR11","doi-asserted-by":"crossref","unstructured":"Rivkees SA, Szarfman A (2010) Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J\u00a0Clin Endocrinol Metab 95:3260\u20133267","DOI":"10.1210\/jc.2009-2546"},{"key":"3196_CR12","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00268-012-1617-x","volume":"36","author":"Annerbo","year":"2012","unstructured":"Annerbo M, Stalberg P, Hellman P (2012) Management of Grave\u2019s disease is improved by total thyroidectomy. World J Surg 36:1943\u20131946","journal-title":"World J Surg"},{"key":"3196_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","volume":"158","author":"Laurberg","year":"2008","unstructured":"Laurberg P, Wallin G, Tallstedt L et\u00a0al (2008) TSH-receptor autoimmunity in Graves\u2018 disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158:69\u201375","journal-title":"Eur J Endocrinol"},{"key":"3196_CR14","doi-asserted-by":"crossref","unstructured":"Clementi M, Di GE, Cassina M et\u00a0al (2010) Treatment of hyperthyroidism in pregnancy and birth defects. J\u00a0Clin Endocrinol Metab 95:E337\u2013E341","DOI":"10.1210\/jc.2010-0652"},{"key":"3196_CR15","first-page":"127","volume":"28","author":"McNab","year":"2005","unstructured":"McNab T, Ginsberg J (2005) Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves\u2018 disease. Clin Invest Med 28:127\u2013131","journal-title":"Clin Invest Med"},{"key":"3196_CR16","doi-asserted-by":"crossref","unstructured":"Klintschar M, Schwaiger P, Mannweiler S et\u00a0al (2001) Evidence of fetal microchimerism in Hashimoto\u2019s thyroiditis. J\u00a0Clin Endocrinol Metab 86:2494\u20132498","DOI":"10.1210\/jc.86.6.2494"},{"key":"3196_CR17","first-page":"812","volume":"Endocrinol","author":"Tanda","year":"2008","unstructured":"Tanda ML, Piantanida E, Lai A et\u00a0al (2008) Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clin Endocrinol (Oxf) 69:812\u2013818","journal-title":"Clin"},{"key":"3196_CR18","first-page":"433","volume":"Endocrinol","author":"Diehl","year":"2006","unstructured":"Diehl LA, Romaldini JH, Graf H et\u00a0al (2006) Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey. Clin Endocrinol (Oxf) 65:433\u2013438","journal-title":"Clin"},{"key":"3196_CR19","doi-asserted-by":"crossref","unstructured":"Eskes SA, Endert E, Fliers E et\u00a0al (2012) Treatment of amiodarone-induced thyrotoxicosis type\u00a02: a randomized clinical trial. J\u00a0Clin Endocrinol Metab 97:499\u2013506","DOI":"10.1210\/jc.2011-2390"},{"key":"3196_CR20","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1210\/en.2010-0199","volume":"151","author":"Neumann","year":"2010","unstructured":"Neumann S, Huang W, Eliseeva E et\u00a0al (2010) A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. Endocrinology 151:3454\u20133459","journal-title":"Endocrinology"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3196-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-012-3196-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3196-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:17:34Z","timestamp":1558585054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-012-3196-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["3196"],"URL":"https:\/\/doi.org\/10.1007\/s00108-012-3196-1","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,8]]}}}